AUPH
Aurinia Pharmaceuticals (AUPH) Investor Questions
Review Aurinia Pharmaceuticals (AUPH) faq with company data, supporting context and links to related investor research.
Research record updated: . Individual measures may refer to different reporting periods.
- Company
- Aurinia Pharmaceuticals
- Sector
- Healthcare
- Industry
- Biotechnology
- Overall BTI score
- 81
- Annual revenue
- $283.06M
- Annual net income
- $287.20M
- Annual free cash flow
- $135.41M
Aurinia Pharmaceuticals (AUPH) Investor Questions research
Aurinia Pharmaceuticals trades under the ticker AUPH. The company is classified in the Healthcare sector and the Biotechnology industry.
Investors commonly review AUPH through its earnings trend, revenue, free cash flow, balance sheet, valuation and historical risk. Use the financial statements to check whether reported profit is supported by cash generation.